Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Dipyridamole may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
Dipyridamole MR 4. Possible side effects 5. How to store Dipyridamole MR
not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Dipyridamole MR Keep out of the sight and reach of children. This medicinal product does not require any special temperature storage conditions. Keep the bottle tightly closed. Store in the original package, in order to protect from moisture. Do not open the container until you are ready to begin taking this course of treatment. Discard any remaining capsules 30 days after first opening the bottle. Do not use Dipyridamole MR after the expiry date which is stated on the bottle/label after 'Exp'. The expiry date refers to the last day of that month. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
6. Content of the pack and other information What Dipyridamole MR contains
The active substance (which makes the medicine work) is 200 mg dipyridamole. The other ingredients are: hypromellose, tartaric acid, acacia, povidone, methacrylic acid-methyl methacrylate copolymer (1:2), hypromellose phthalate, dimethicone, triacetin, talc and stearic acid. The HPMC capsule shell contains: Hypromellose, brilliant blue (E133), ponceau 4R (E124), quinoline yellow (E104), titanium dioxide (E171), Carrageenan and Potassium Acetate. The white imprinting ink contains: shellac, potassium hydroxide and titanium dioxide (E171).
What Dipyridamole MR looks like and contents of the pack
Dipyridamole MR is a modified-release capsule filled with yellow to orange coloured pellets filled in size "0xel" hard capsules with opaque dark red cap and opaque dark orange body, imprinted 'DPM' on cap and '200' on body with white ink. Dipyridamole MR capsules are supplied in HDPE bottles, with desiccant. Pack size: 60 capsules per bottle.
Marketing authorisation holder and manufacturer Dr. Reddy's Laboratories (UK) Ltd., 6 Riverview Road, Beverley, HU17 0LD
This leaflet was last updated in 09/2019
40 mm
Throughout this leaflet Dipyridamole Dr Reddy's 200 mg Modified-Release Capsules, Hard is referred to as Dipyridamole MR. Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
40 mm
PACKAGE LEAFLET: INFORMATION FOR THE USER Dipyridamole Dr Reddy's 200 mg Modified-Release Capsules, Hard Dipyridamole
40 mm
130 mm
30 mm
20 mm
Process Black
9pt India 150 x 270 mm
If you take more Dipyridamole MR than you should
Do not take more than your doctor has prescribed. It may cause symptoms such as feeling warm, sweating, racing of pulse, restlessness, weakness, dizziness and chest pain. If you take more than the recommended daily dose, consult a doctor or go to a hospital straight away. Take the medicine pack with you, even if there are no capsules left.
If you forget to take Dipyridamole MR
If you forget to take a dose, take it as soon as you remember but if it is nearly time for your next dose, skip the missed dose. Do not take a double dose to make up for a forgotten dose. If you have any further questions on the use of this product, ask your doctor or pharmacist.
4. Possible side effects Like all medicines, Dipyridamole MR can cause side effects, although not everybody gets them.
Contact your doctor at once if you develop any of the following rare allergic reactions: • •
breathing difficulties large welts or swelling of the skin near the eyes, lips, hands, feet or inside of the throat (which may cause difficulty breathing), runny nose and severe rash with itching.
Other side effects that have been reported are described below. They are listed as either very common, common or not known.
Very common (may affect more than 1 in 10 people) • • • •
headache feeling dizzy feeling sick (nausea) diarrhoea
Common (may affect up to 1 in 10 people) • • •
muscle pain being sick (vomiting) worsening of symptoms of heart disease such as chest pain (angina) and heart beat problems (arrhythmias), fatigue, breathlessness
Not known (frequency cannot be estimated from the available data) • • •
hot flushes lowering of blood pressure or increased heart rate a blood problem called 'thrombocytopenia' which can cause bruising and prolonged bleeding from wounds including during or after surgery.
Reporting of side effects
If you get any side effects, talk to your doctor, hospital pharmacist or nurse. This includes any
Dipyridamole Dr. Reddy's 200 mg Modified-Release Capsules, Hard comes as capsule containing 200mg. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Dipyridamole Dr. Reddy's 200 mg Modified-Release Capsules, Hard is dipyridamole.
Medicines with the same active substance, strength and form include: Attia 200 mg Modified-Release Capsules, Hard, Dipyridamole 200 mg Prolonged Release Capsules, Hard. They are interchangeable only if your prescriber or pharmacist says so.
This leaflet reproduces the patient information leaflet approved for Dipyridamole Dr. Reddy's 200 mg Modified-Release Capsules, Hard, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
Ask anything about Dipyridamole Dr. Reddy’s 200 mg Modified-Release Capsules, Hard. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.